REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 52.00
Ask: 54.00
Change: 0.50 (0.95%)
Spread: 2.00 (3.846%)
Open: 53.00
High: 53.00
Low: 52.50
Prev. Close: 52.50
CLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

10 Oct 2023 15:17

RNS Number : 6739P
Calnex Solutions PLC
10 October 2023
 

This announcement contains inside information

 

10 October 2023

 

Calnex Solutions plc

("Calnex", the "Company" or the "Group")

 

Trading Update and Notice of Results

 

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets, provides an update on trading and outlook for the full year to 31 March 2024 ("FY24") and beyond.

 

In the first six months of FY24, the Company's order inflow has remained at the subdued levels experienced at the start of the year, with the precise timing of future customer orders remaining uncertain. The cautiously improving outlook for the sector identified earlier this year has not developed momentum and the Company is aware that certain customers have elected to delay projects and associated orders in response to continuing wider economic uncertainty. These factors have led the Board to conclude that H2 FY24 will be slower than anticipated.

 

The challenging market conditions mean the Board now anticipates that, whilst revenues are expected to increase in H2 versus H1, revenues for FY24 will be in the region of 20-30 per cent below current market expectations, depending on the timing of orders. No customer orders have been cancelled and all are expected to be fulfilled once the delays to customer project spending are relaxed.

 

The Company's balance sheet remains robust, with cash at the end of September 2023 of £13.5 million, following investment in inventory. The cash position enables the Company to continue to target growth opportunities in its key sectors and maintain relationships with customers as they plan future investment in their projects.

 

Calnex's sales pipeline remains strong and the Company's close relationships with its customers leaves it well positioned to convert the sales pipeline to orders once spending patterns normalise.

 

The Board is confident in a return to growth in FY25, with Calnex able to deploy its suite of products to target opportunities in both the Telecoms and Cloud-computing and related sectors. Costs are closely monitored with investment in new products subject to stringent assessment.

 

The Company is actively targeting new markets with its expanded product range, and recently launched, or soon to be launched, enhanced product lines within existing and new key markets, include:

 

· Sentry timing product to address the large data centre market.

· SNE-Ignite and SNE-X products have been designed to prove the performance of new, real-time cloud-based applications.

· NE-ONE, Calnex's recently acquired network emulation product, is targeting defence and government markets.

· Enhancement to the Paragon platform, through a major new release in H2 FY25 to support leading edge 800Gb/s interface testing.

· SyncSense, Calnex's newly-developed data centre and telecom network management timing product, has been well received by customers.

 

These products will enhance penetration in the Company's target markets, reinforcing the potential for growth in FY25 and beyond.

 

Notice of Results

 

The Company intends to announce unaudited results for the six months ended 30 September 2023 on Tuesday 21 November 2023.

 

Tommy Cook, Chief Executive Officer, and founder of Calnex, said: "Whilst the telecommunications market outlook is currently challenging, the expansion of our product portfolio to areas outside of telecommunications and our strong sales pipeline mean we are confident in a return to growth in FY25.

 

"Looking to the longer-term, the underlying market drivers continue to build, such as the need to upgrade telecoms infrastructure to deliver the promise of 5G, and to enhance data centre operations to support the demand for cloud computing and advancements in AI and Virtual Reality technologies. As a result, our confidence in the long-term prospects for Calnex remains high."

 

 

For more information, please contact:

 

Calnex Solutions plc

Via Alma PR

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cavendish Securities plc - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

 

Alma

+ 44(0) 20 3405 0213

Caroline Forde, Hannah Campbell, Joe Pederzolli

 

 

Overview of Calnex

 

Calnex Solutions designs, produces and markets test and measurement instrumentation and solutions for the telecoms and cloud computing industries. Calnex's portfolio enables R&D, pre-deployment and in-service testing for network technologies and networked applications, enabling its customers to validate the performance of the critical infrastructure associated with telecoms and cloud computing networks and the applications that run on it.

 

To date, Calnex has secured and delivered orders in 68 countries across the world. Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Meta.

 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing a worldwide distribution capability. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBSBDGUBBDGXG
Date   Source Headline
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 202111:03 amRNSHolding(s) in Company
15th Oct 20219:33 amRNSPDMR Dealing
12th Oct 20217:00 amRNSTrading Update
7th Sep 20217:00 amRNSAward of Options
19th Aug 20215:05 pmRNSResult of AGM
19th Aug 20217:00 amRNSAGM Statement
4th Aug 20214:34 pmRNSHolding(s) in Company
15th Jul 20212:53 pmRNSDirector Dealing
28th Jun 20217:00 amRNSNotice of AGM and Posting of Annual Report
16th Jun 20214:26 pmRNSPDMR Dealing
25th May 20217:00 amRNSFY21 Final Results
17th May 20217:00 amRNSNotice of Results and Investor Presentation
15th Apr 202112:31 pmRNSPDMR Shareholding
1st Apr 20214:05 pmRNSPDMR/PCA Dealing
24th Mar 20214:14 pmRNSPDMR Dealing
16th Feb 20217:00 amRNSTrading Update
1st Feb 20213:53 pmRNSPDMR Dealing
10th Dec 20202:05 pmRNSSecond Price Monitoring Extn
10th Dec 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
25th Nov 20209:00 amRNSPrice Monitoring Extension
25th Nov 20207:00 amRNSInterim Results
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
12th Oct 20206:10 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.